A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full applications. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: November 30 - December 1, 2015

Wan Lam, PhD (Chair) BC Cancer Agency

Vancouver, BC
Kevin Bennewith, PhD BC Cancer Agency

Vancouver, BC
Jim Davie, Phd University of Manitoba

Winnipeg, MB
Robert Day, PhD  University of Sherbrooke

Sherbrooke, QC
Harriet Feilotter, PhD Queen’s University

Kingston, ON
Michael Hendzel, PhD  University of Alberta

Edmonton, AB
Annie Huang, MD/PhD The Hospital for Sick Children

Toronto, ON
Rayjean Hung, PhD Mount Sinai Hospital

Toronto, ON
Maja Krajinovic, MD/PhD University of Montreal

Montreal, QC
William Lockwood, PhD BC Cancer Agency

Vancouver, BC
Julian Lum, PhD  BC Cancer Agency

Vancouver, BC
Sylvie Mader, PhD Institute for Research in Immunology and Cancer (IRIC)

Montreal, QC
Christopher Mueller, PhD Queen’s University

Kingston, ON
Robert Sladek, MD McGill University

Montreal, QC
Christian Steidl, MD BC Cancer Research Centre

Vancouver, BC
Pierre Thibault, PhD Institute for Research in Immunology and Cancer (IRIC)

Montreal, QC
Steve Bilodeau, PhD (Scientific Officer) Centre Hospitalier Universitaire de Quebec (CHUQ)

Quebec City, QC
Troy Harkness, PhD (Scientific Officer) University of Saskatchewan

Saskatoon, SK
Valerie Gauvin (Community Representative) Canadian Cancer Society – British Columbia / Yukon Division
Sean Nurmsoo (Community Representative) Canadian Cancer Society – Nova Scotia Division

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: December 2-3, 2015

John White, PhD (Chair) McGill University

Montreal, QC
Deborah Anderson, PhD University of Saskatchewan

Saskatoon, SK
David Brindley, PhD University of Alberta

Edmonton, AB
Jocelyn Côté, PhD University of Ottawa

Ottawa, ON
Daniel Durocher, PhD Lunenfeld-Tanenbaum Research Institute

Toronto, ON
Imed Gallouzi, PhD  McGill University

Montreal, QC
Murray Junop, PhD Western University

London, ON
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)

Montreal, QC
Susan Lees-Miller, PhD University of Calgary

Calgary, AB
C Jane McGlade, PhD The Hospital for Sick Children

Toronto, ON
Gil Privé, PhD Princess Margaret Cancer Centre

Toronto, ON
Janusz Rak, MD/PhD Research Institute of the McGill University Health Centre

Montreal, QC
Brian Raught, PhD Princess Margaret Cancer Centre

Toronto, ON
Igor Stagljar, PhD University of Toronto

Toronto, ON
Julie St-Pierre, PhD McGill University

Montreal, QC
Uri Tabori, MD The Hospital for Sick Children

Toronto, ON
Leonardo Salmena, PhD (Scientific Officer) University of Toronto

Toronto, ON 
Jim Uniacke, PhD (Scientific Officer) University of Guelph

Guelph, ON
Michael Jensen (Community Representative) Canadian Cancer Society – Ontario Division
Vanessa Steen (Community Representative) Canadian Cancer Society – Ontario Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: December 1-2, 2015

Michael Patterson, PhD (Chair) McMaster University

Hamilton, ON
Daniel Côté, PhD  Laval University

Quebec City, QC 
Todd Hoare, PhD McMaster University

Hamilton, ON
Marianna Koritzinsky, PhD Princess Margaret Cancer Centre

Toronto, ON
Piotr Kozlowski, PhD University of British Columbia

Vancouver, BC
Boyd McCurdy, PhD CancerCare Manitoba

Winnipeg, MB
Andrew Minchinton, PhD BC Cancer Agency

Vancouver, BC
Alan Nichol, MD BC Cancer Agency

Vancouver, BC
Mark Niedre, PhD  Northeastern University

Boston, MA
Brian Nieman, PhD  The Hospital for Sick Children

Toronto, ON 
Christopher Phenix, PhD  Thunder Bay Regional Research Institute

Thunder Bay, ON 
Tim Salcudean, PhD University of British Columbia

Vancouver, BC
Jack Tuszynski, PhD University of Alberta

Edmonton, AB
Frank Wuest, PhD University of Alberta

Edmonton, AB
Rebecca Thornhill, PhD (Scientific Officer) University of Ottawa

Ottawa, ON
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre

London, ON
Donna Murrell (Community Representative) Canadian Cancer Society – Ontario Division
Angie Woodcock (Community Representative) Canadian Cancer Society – Ontario Division

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: December 3-4, 2015

Ben Alman, MD (Chair) Duke University

Durham, NC
Laurie Ailles, PhD Princess Margaret Cancer Centre

Toronto, ON
Michele Anderson, PhD Sunnybrook Health Sciences Centre

Toronto, ON
David Brooks, PhD Princess Margaret Cancer Centre

Toronto, ON
Javier Di Noia, PhD IRCM - Institut de Recherches Cliniques de Montréal

Montreal, QC
David Evans, PhD University of Alberta

Edmonton, AB
William Jia, PhD University of British Columbia

Vancouver, BC
Sam Kung, PhD University of Manitoba

Winnipeg, MB
Andrew Makrigiannis, PhD University of Ottawa

Ottawa, ON
Mark Minden, MD/PhD  Princess Margaret Cancer Centre

Toronto, ON
Lisa Porter, PhD University of Windsor

Windsor, ON
Josie Ursini-Siegel, PhD Lady Davis Institute

Montreal, QC
André Veillette, MD IRCM - Institut de Recherches Cliniques de Montréal

Montreal, QC
Kristin Hope, PhD (Scientific Officer) McMaster University

Hamilton, ON
Heather Melichar, PhD (Scientific Officer) Hopital Maisonneuve-Rosemont

Montreal, QC
Kathryn Dickinson (Community Representative) Canadian Cancer Society – Ontario Division
Diane Hawrylenko (Community Representative) Canadian Cancer Society – Ontario Division

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: December 8-9, 2015

Michel Roberge, PhD (Chair) University of British Columbia

Vancouver, BC
Robert Britton, PhD Simon Fraser University

Burnaby, BC
Warren Chan, PhD University of Toronto

Toronto, ON
Daniel De Carvalho, PhD Princess Margaret Cancer Centre

Toronto, ON
Mark Glover, PhD University of Alberta

Edmonton, AB
Scott Laurie, MD University of Ottawa

Ottawa, ON
Fei-Fei Liu, MD Princess Margaret Cancer Centre

Toronto, ON
Christopher Maxwell, PhD University of British Columbia

Vancouver, BC
Sylvain Meloche, PhD Institute for Research in Immunology and Cancer (IRIC)

Montreal, QC
Alain Nepveu, PhD  McGill University

Montreal, QC 
Kevin Petrecca, MD/PhD  McGill University

Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta

Edmonton, AB
Leigh Revers, PhD University of Toronto

Toronto, ON
Murray Webb, PhD The Centre for Drug Research and Development (CDRD)

Vancouver, BC
Amina Zoubeidi, PhD University of British Columbia

Vancouver, BC
Philippe Bedard, MD (Scientific Officer) Princess Margaret Cancer Centre

Toronto, ON
Rebecca Laposa, PhD (Scientific Officer) University of Toronto

Toronto, ON
Dawn Ashforth (Community Representative) Canadian Cancer Society – Ontario Division
Laura Mullin (Community Representative) Canadian Cancer Society – Ontario Division

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: December 7, 2015

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center

New York, NY
Andrea Cherrington, MD  University of Alabama at Birmingham

Birmingham, AL
Hugh Davies, PhD  University of British Columbia

Vancouver, BC 
Igor Karp, PhD Western University

London, ON
Karen Kopciuk, PhD  Alberta Health Services

Calgary, AB 
Robert Reid, PhD/MBA University of Ottawa Heart Institute

Ottawa, ON
Brenda Sabo, RN/PhD Dalhousie University

Halifax, NS
Jennifer Stinson, RN/PhD The Hospital for Sick Children

Toronto, ON
Jonathan Sussman, MD Juravinski Cancer Centre

Hamilton, ON
Thomas Tenkate, PhD Ryerson University

Toronto, ON
Alice Wei, MD  Princess Margaret Cancer Centre

Toronto, ON
Darren Brenner, PhD (Scientific Officer) Alberta Health Services Cancer Control

Calgary, AB
Melanie Keats, PhD (Scientific Officer) Dalhousie University

Halifax, NS
Mili Baghela (Community Representative) Canadian Cancer Society – British Columbia / Yukon Division
Genevieve Roussy, PhD (Community Representative) Canadian Cancer Society – New Brunswick Division

 

Impact Grant panel

LOI review teleconference: June 23, 2015

Panel meeting: November 19, 2015

John Bell, PhD (Co-Chair) Ottawa Hospital Research Institute

Ottawa, ON 
Michael Brundage, MD (Co-Chair) Kingston General Hospital

Kingston, ON
Samuel Aparicio, PhD BC Cancer Research Centre

Vancouver, BC
Marcel Bally, PhD BC Cancer Agency



Vancouver, BC
*Mick Bhatia, PhD McMaster University



Hamilton, ON
Deborah Bowen, PhD University of Washington

Seattle, WA
Shoukat Dedhar, PhD BC Cancer Agency

Vancouver, BC
*Steven Gallinger, MD  Toronto General Hospital

Toronto, ON 
Peter Greer, PhD Queen’s University

Kingston, ON
Cynthia Hawkins, MD/PhD  The Hospital for Sick Children

Toronto, ON
Nada Jabado, MD/PhD McGill University

Montreal, QC
*Rama Khokha, PhD  Ontario Cancer Institute/PMCC

Toronto, ON 
*Nathalie Labrecque, PhD University of Montreal

Montreal, QC
Calum MacAulay, PhD  BC Cancer Agency

Vancouver, BC 
*Warren Mason, MD/PhD Princess Margaret Cancer Centre

Toronto, ON
*Matthew Parliament, MD  Cross Cancer Institute

Edmonton, AB
Claude Perreault, MD  IRIC

Montreal, QC 
Janet Rossant, PhD The Hospital for Sick Children

Toronto, ON
*Gurmit Singh, PhD  McMaster University

Hamilton, ON 
*Lillian Siu, MD Princess Margaret Cancer Centre

Toronto, ON
*Nahum Sonenberg, PhD McGill University

Montreal, QC
John Spinelli, PhD BC Cancer Agency

Vancouver, BC
Lillian Sung, MD/PhD The Hospital for Sick Children

Toronto, ON
*Scott Tyldesley, MD BC Cancer Agency

Vancouver, BC
*Jeffrey Wrana, PhD Mount Sinai Hospital

Toronto, ON
*Camilla Zimmermann, MD/PhD Princess Margaret Cancer Centre

Toronto, ON
Anand Swaminath, MD (Scientific Officer) Juravinski Cancer Centre

Hamilton, ON
Matthew Creighton (Community Representative) Canadian Cancer Society –Alberta/NWT Division
Judy Lund (Community Representative) Canadian Cancer Society – Ontario Division

Prevention Research Grant panel

LOI review teleconference: April 4, 2016

Panel meeting: September 26, 2016

>
Eduardo Franco, MPH/PhD(Chair)  McGill University

Montreal, QC
Irene Andrulis, PhD  Mount Sinai Hospital

Toronto, ON 
Sunday Azagba, PhD University of Waterloo

Waterloo, ON
Louise Brinton, PhD/MPH National Cancer Institute

Rockville, MD
Michael Chaiton, PhD University of Toronto

Toronto, ON
Claire de Oliveira, PhD Centre for Addiction and Mental Health

Toronto, ON
Walter Gotlieb, MD/PhD  Jewish General Hospital

Montreal, QC 
Emmanuel Guindon, PhD McMaster University

Hamilton, ON
Melissa Henry, PhD Jewish General Hospital

Montreal, QC
Nancy Kreiger, MPH/PhD/FACE University of Toronto

Toronto, ON
Anthony Miller, MD/FACE University of Toronto

Toronto, ON
Lisa Mirabello, PhD National Cancer Institute

Rockville, MD
Jennifer O'Loughlin, PhD CRCHUM, University of Montreal

Montreal, QC
Lawrence Paszat, MD University of Toronto

Toronto, ON
Harriet Richardson, PhD Queen’s University

Kingston, BC
Beti Thompson, PhD Fred Hutchinson Cancer Research Center

Seattle, WA
Amy Yaroch, PhD Gretchen Swanson Center for Nutrition

Omaha, NE
Regina Ziegler, PhD/MPH National Cancer Institute

Rockville, MD 
Geetanjali Datta, PhD (Scientific Officer) University of Montreal

Montreal, QC 
Leia Minaker, PhD (Scientific Officer) University of Waterloo

Waterloo, ON

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014

Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky

Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal

Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University

Boston, MA, USA 
Anne Leis, PhD University of Saskatchewan

Saskatoon, SK
S. Elizabeth McGregor, PhD  Alberta Health Services

Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba

Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine

St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University

Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University

> Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division

Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division

Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health

Mississauga, ON

Career Development Awards in Prevention panel

Panel meeting: June 18, 2015

Julia Knight, PhD (Chair)  Mount Sinai Hospital

Toronto, ON
Joan L. Bottorff, PhD/RN University of British Columbia Okanagan

Kelowna, BC
Katherine Frohlich, PhD University of Montreal

Montreal, QC
Shelley Harris, PhD CancerCare Ontario

Toronto, ON
Salaheddin Mahmud, PhD University of Manitoba

Winnipeg, MB
Jennifer Yessis, PhD  University of Waterloo

Waterloo, ON

Quality of Life Grant panel

LOI review teleconference: September 18, 2015

Panel meeting: January 14, 2016

Jamie Studts, PhD 

(Chair)
University of Kentucky

Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre

Toronto, ON
*Cristina Caperchione, PhD University of British Columbia (Okanagan)

Kelowna, BC
Anees Chagpar, MD Yale University

New Haven, CT
S. Robin Cohen, PhD McGill University

Montreal, QC 
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute

Tampa, FL
David Eisenstat, MD University of Alberta

Edmonton, AB 
Sophie Lebel, PhD University of Ottawa

Ottawa, ON
Christopher Longo, PhD McMaster University

Hamilton, ON
*Donald Mabbott, PhD The Hospital for Sick Children

Toronto, ON
*Christine Maheu, PhD McGill University

Montreal, QC 
Suzanne O’Neill, PhD Georgetown University

Washington, DC
Dean Regier, PhD  BC Cancer Agency

Vancouver, BC 
*Tara Schapmire, PhD  University of Louisville

Louisville, KY
*Allen Sherman, PhD  University of Arkansas

Little Rock, AR 
Marcy Winget, PhD Stanford University

Stanford, CA 
Rebecca Wong, MD  Princess Margaret Cancer Centre

Toronto, ON
James Wright, MD Juravinski Cancer Centre

Hamilton, ON 
*Eitan Amir, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre

Toronto, ON 
Lauren Walker, PhD (Scientific Officer) Tom Baker Cancer Centre

Calgary, AB
Ryan Normore (Community Representative) Canadian Cancer Society - Nova Scotia Division
Cindy Vinall (Community Representative) Canadian Cancer Society - Ontario Division

Knowledge to Action Grant panel

Panel meeting: May 14, 2015

David Chambers, PhD (Chair)  National Cancer Institute

Rockville, MD
Lisa Barbera, PhD  Sunnybrook Research Institute

Toronto, ON 
Jamie Brehaut, PhD  Ottawa Hospital Research Institute

Ottawa, ON 
Nicole Culos-Reed, PhD University of Calgary

Calgary, AB 
Arminee Kazanjian, PhD  University of British Columbia

Vancouver, BC 
Rodger Kessler, PhD University of Vermont

Burlington, VT
Anita Kothari, PhD  Western University

London, ON
Monika Krzyzanowska, MD/MPH  Princess Margaret Cancer Centre

Toronto, ON 
Martine Puts, PhD University of Toronto

Toronto, ON 
Barbara Riley, PhD University of Waterloo

Waterloo, ON
Robert Schwartz, PhD  University of Toronto

Toronto, ON
Marko Simunovic, MD/MPH Juravinski Caner Clinic

Hamilton, ON
Jennifer Brunet, PhD (Scientific Officer)  University of Ottawa

Ottawa, ON 
Shannon Sibbald, PhD (Scientific Officer) Western University

London, ON
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon Division
Sean Nurmsoo (Community Representative) Canadian Cancer Society - Nova Scotia Division

Last modified on: February 11, 2016